Asia‐Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms

Contemporary systems for the diagnosis and management gastrointestinal symptoms not attributable to organic diseases (Functional GI Disorders, FGID, now renamed Disorders of Gut‐Brain Interaction, DGBI) seek to categorize patients into narrowly defined symptom‐based sub‐classes to enable targeted tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastroenterology and hepatology 2023-02, Vol.38 (2), p.197-209
Hauptverfasser: Gwee, Kok‐Ann, Lee, Yeong Yeh, Suzuki, Hidekazu, Ghoshal, Uday Chand, Holtmann, Gerald, Bai, Tao, Barbara, Giovanni, Chen, Min‐hu, Chua, Andrew Seng Boon, Gibson, Peter R, Hou, Xiaohua, Liu, Jinsong, Nakajima, Atsushi, Pratap, Nitesh, Sachdeva, Sanjeev, Siah, Kewin Tien Ho, Soh, Alex Yu Sen, Sugano, Kentaro, Tack, Jan, Tan, Victoria Ping Yi, Tang, Xudong, Walker, Marjorie, Wu, Deng‐Chyang, Xiao, Ying‐Lian, Zulkifli, Khairil Khuzaini, Toh, Clarissa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Contemporary systems for the diagnosis and management gastrointestinal symptoms not attributable to organic diseases (Functional GI Disorders, FGID, now renamed Disorders of Gut‐Brain Interaction, DGBI) seek to categorize patients into narrowly defined symptom‐based sub‐classes to enable targeted treatment of patient cohorts with similar underlying putative pathophysiology. However, an overlap of symptom categories frequently occurs and has a negative impact on treatment outcomes. There is a lack of guidance on their management. An Asian Pacific Association of Gastroenterology (APAGE) working group was set up to develop clinical practice guidelines for management of patients with functional dyspepsia (FD) who have an overlap with another functional gastrointestinal disorder: FD with gastroesophageal reflux (FD‐GERD), epigastric pain syndrome with irritable bowel syndrome (EPS‐IBS), postprandial distress syndrome with IBS (PDS‐IBS), and FD‐Constipation. We identified putative pathophysiology to provide a basis for treatment recommendations. A management algorithm is presented to guide primary and secondary care clinicians.
ISSN:0815-9319
1440-1746
DOI:10.1111/jgh.16046